Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Nat Genet 2020 Nov
Cancer therapy shapes the fitness landscape of clonal hematopoiesis.
Related Questions
Would you offer a bone marrow biopsy to the patient with normal CBC and low MDS-associated mutation burden found on NGS?
E.g. TET2 mutation at < 10% allele frequency
New comment
by Medical Oncologist at The Center for Hematology and Oncology at Holy Cross Hospital ( June 22, 2023)
Agree. Would not do it, marrow biopsy.
Read more (1 Answer available)
16674
×
To continue please login or register
Register
or
Sign in